Buy or sell Synthego stock pre IPO via an EquityZen fund
Genome Engineering Solutions
About Synthego Stock
Synthego is a provider of genome engineering solutions.The company's flagship product, CRISPRevolution, is a portfolio of synthetic RNA designed for CRISPR genome editing and research. CRISPR genome engineering technology enables scientists to easily and precisely edit the DNA of any genome. Select applications of gene editing include: pathway analysis, stem cells, and diagnostics. The company also offers two products: CRISPR-edited iPS cells and Engineered Cells. See here for more detailed information on Synthego's products.
Synthego aims to bring precision and automation to genome engineering, enabling rapid and costeffective research with consistent results for every scientist.
The company is headquartered in Silicon Valley, California and was founded in July 2012.
Arab Angel Fund
Chief Executive Officer
Chief Operating Officer
Benzinga - Oct, 15 2020
zpr - Sep, 3 2020
PR Newswire - Jan, 14 2020